Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rajwant Sodhi Insider Profile
4 Followers
Rajwant Sodhi, President, SaaS Business at Resmed, holds 6.70K shares in Tandem Diabetes Care (Ticker: TNDM), holds 26.73K shares in Resmed (Ticker: RMD). Most recently, Rajwant Sodhi Bought ― shares of Tandem Diabetes Care on Jan 08, 2024 for an estimated value of 29.60K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-1.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rajwant Sodhi holds in companies
Most Profitable Insider Trade
The most profitable trade made by Rajwant Sodhi
Rajwant Sodhi's Trading History
Resmed
Sep 03, 2021
President, SaaS Business
Uninformative Sell
432.62K
$5.80M
Tandem Diabetes Care
Jan 08, 2024
Director
Informative Buy
29.60K
$295.13K
List of latest transactions for each holding click on a transaction to see Rajwant Sodhi's performance on stock
You May Also Like
Rajwant Sodhi insider profile FAQ
What is the percentage of profitable transactions made by Rajwant Sodhi?
The percentage of profitable transactions made by Rajwant Sodhi is 50%.
What is the average return per transaction made by Rajwant Sodhi?
The average return per transaction made by Rajwant Sodhi is -1.80%.
What stocks does Rajwant Sodhi hold?
Rajwant Sodhi holds: RMD, TNDM stocks.
What was Rajwant Sodhi’s latest transaction?
Rajwant Sodhi latest transaction was an Informative Buy of $29.60K.
What was Rajwant Sodhi's most profitable transaction?
Rajwant Sodhi’s most profitable transaction was an Informative Buy of TNDM stock on January 8, 2024. The return on the trade was 58.00%.
What is Rajwant Sodhi's role in Resmed?
Rajwant Sodhi's role in Resmed is President, SaaS Business.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.